Glutaric Aciduria Type 1: A Case Report and Review of Literature

Abstract An 8-month-old male infant patient was referred to our institution (from elsewhere) with a history of fever, convulsions, dystonic posturing, altered sensorium, and loss of motor and mental milestones since past 1 month. Upon admission to our institution, a neuroimaging (magnetic resonance imaging of the brain) revealed frontoparietal atrophy, “bat-wing appearance,” and basal ganglia changes. Carnitine and acylcarnitine profile revealed low total carnitine, very low free carnitine, and low free/acylcarnitine ratio, with normal levels of plasma amino acids. Urine gas chromatography mass spectrometry showed an elevated level of ketones (3-hydroxybutyric acid and acetoacetate) and glutaric acid with the presence of 3-hydroxyglutaric acid, suggestive of glutaric aciduria type 1. Diet modification and pharmacotherapy with riboflavin and carnitine arrested the neurological deterioration in the patient.

[1]  S. Goodman,et al.  An explanation for metabolite excretion in high- and low-excretor patients with glutaric acidemia type 1. , 2019, Molecular genetics and metabolism.

[2]  D. Attwell,et al.  Glutaric Acid Affects Pericyte Contractility and Migration: Possible Implications for GA-I Pathogenesis , 2019, Molecular Neurobiology.

[3]  R. Manara,et al.  Malignant brain tumors in patients with glutaric aciduria type I. , 2018, Molecular Genetics and Metabolism.

[4]  A. Sitta,et al.  Oxidative damage in glutaric aciduria type I patients and the protective effects of l‐carnitine treatment , 2018, Journal of cellular biochemistry.

[5]  S. Kapoor,et al.  Status of Newborn Screening and Inborn Errors of Metabolism in India , 2018, The Indian Journal of Pediatrics.

[6]  F. Natacci,et al.  Early neonatal Glutaric aciduria type I hidden by perinatal asphyxia: a case report , 2018, Italian Journal of Pediatrics.

[7]  S. Kure,et al.  Reversible brain atrophy in glutaric aciduria type 1 , 2017, Brain and Development.

[8]  G. C,et al.  Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I , 2017, Metabolic Brain Disease.

[9]  Johannes Zschocke,et al.  Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision , 2017, Journal of Inherited Metabolic Disease.

[10]  T. Fuchigami,et al.  Severe Acute Subdural Hemorrhages in a Patient with Glutaric Acidemia Type 1 under Recommended Treatment , 2016, Pediatric Neurosurgery.

[11]  H. Fu,et al.  Recurrent rhabdomyolysis and glutaric aciduria type I: a case report and literature review , 2016, World Journal of Pediatrics.

[12]  Ishan Kumar,et al.  Magnetic resonance spectroscopy — Revisiting the biochemical and molecular milieu of brain tumors , 2016, BBA clinical.

[13]  N. Salamon,et al.  Adult-onset glutaric aciduria type I presenting with white matter abnormalities and subependymal nodules , 2015, neurogenetics.

[14]  S. Mohammad,et al.  Glutaric aciduria type 1: neuroimaging features with clinical correlation , 2015, Pediatric Radiology.

[15]  S. Bhuta,et al.  Rare presentation of a treatable disorder: glutaric aciduria type 1. , 2015, The New Zealand medical journal.

[16]  O. Glenn,et al.  Teaching NeuroImages: Infant with glutaric aciduria type 1 presenting with infantile spasms and hypsarrhythmia , 2013, Neurology.

[17]  S. Listl,et al.  Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis , 2013, Orphanet Journal of Rare Diseases.

[18]  A. Ribes,et al.  Glutaric aciduria type I: outcome of patients with early- versus late-diagnosis. , 2013, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[19]  C. Hendriksz,et al.  Dietary practices in glutaric aciduria type 1 over 16 years. , 2012, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[20]  M. Wajner,et al.  Marked reduction of Na(+), K(+)-ATPase and creatine kinase activities induced by acute lysine administration in glutaryl-CoA dehydrogenase deficient mice. , 2012, Molecular genetics and metabolism.

[21]  N. Longo,et al.  Glutaric acidemia type 1: outcomes before and after expanded newborn screening. , 2012, Molecular genetics and metabolism.

[22]  K. Carman,et al.  GLUTARIC ACIDURIA TYPE 1 PRESENTING AS SUBDURAL HAEMATOMA , 2012, Journal of paediatrics and child health.

[23]  M. Durán,et al.  Diagnosis and management of glutaric aciduria type I – revised recommendations , 2011, Journal of Inherited Metabolic Disease.

[24]  Q. Garrett,et al.  Role of carnitine in disease , 2010, Nutrition & metabolism.

[25]  R. Jacobs,et al.  Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type I. , 2007, The Journal of clinical investigation.

[26]  A. Ribes,et al.  Natural History, Outcome, and Treatment Efficacy in Children and Adults with Glutaryl-CoA Dehydrogenase Deficiency , 2006, Pediatric Research.

[27]  A. Ozturk,et al.  Diffusion-weighted MR imaging and MR spectroscopy in glutaric aciduria type 1 , 2005, Neuroradiology.

[28]  A. Ribes,et al.  Correlation of genotype and phenotype in glutaryl-CoA dehydrogenase deficiency , 2004, Journal of Inherited Metabolic Disease.

[29]  V. Runge,et al.  Magnetic Resonance Imaging of the Brain in Glutaric Acidemia Type I: A Review of the Literature and a Report of Four New Cases With Attention to the Basal Ganglia and Imaging Technique , 2003, Investigative radiology.

[30]  M. Canpolat,et al.  Glutaric Acidemia Type 1: A Case of Infantile Stroke. , 2018, JIMD reports.

[31]  M. Schwartz,et al.  Glutaryl‐CoA dehydrogenase mutations in glutaric acidemia (type I): Review and report of thirty novel mutations , 1998, Human mutation.

[32]  C. Roe,et al.  A case of glutaric acidemia type I: effect of riboflavin and carnitine. , 1988, The Journal of pediatrics.